populations.
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(1996) [8, 9] . Thiols autooxidize in the presence of metal ions, forming thiyl radicals and superoxide, which promote LDL oxidation [10] . It has been proposed that To date, however, there is no consensus on the predominant mechanism of LDL oxidation in vivo. In vitro, LDL can be modified oxidatively in the presence of transition metals such as iron and copper. LDL oxidized by a cell-free system is physiochemically and biologically indistinguishable from LDL oxidized by a cellular system [2] . In vitro, LDL can bind copper, which can promote rapid lipid peroxidation [17] . LDL can be oxidized in a metal-independent system with 2,2'-azobis(2-amidinopropane) (AAPH), a water-soluble azo compound that thermally decomposes, leading to the formation of aqueous peroxyl radicals at a constant rate [18] . antioxidants, the predominant one being ct-tocopherol. Oxidation of LDL is a free radical-mediated process, resulting in numerous structural changes, all of which depend on a common initiating event, the peroxidation of PUFAs in LDL. The peroxidation of a PUFA is shown in Fig. 1 . Oxidation of LDL is initiated by reactive oxygen species that abstract a H' from a double bond in PUFA, which is followed by molecular Fig. 2 . These indices of oxidation will be discussed in detail later. Cholesterol in LDL can be oxidized to oxysterols such as 7-ketocholesterol [23] . The propagation phase is followed by a decomposition or degradation phase, during which there is cleavage of double bonds, resulting in the formation of aldehydes. The major aldehydes produced include malondialdehyde (MDA), 4-hydroxynonenal (HNE), and hexanal, which can cross-link with amino groups on apo B-l00.
Changes in the protein moiety also occur during the oxidation of LDL [6, 24] . After oxidation, there is an increase in the negative charge on the LDL particle, possibly due to the derivatization of positively charged amino groups through the formation of a Schiff base with aldehydes. Also, after oxidation, apo B-100 undergoes oxidative scission, leading to fragmentation. 
Blologkal Effects of Ox-LDL
Ox-LDL exerts several biological effects that may contribute to the initiation and progression of the atherosclerotic process [2] [3] [4] [5] [6] . A schema depicting the role of Ox-LDL in atherogenesis is shown in Fig. 3 (Fig. 2) shows a lag phase, in which diene absorption shows > only a slight increase, followed by a propagation phase in which 234-nm absorption rapidly increases. In succession, the 234-nm ' absorption decreases, then increases again in the decomposition phase, because the aldehydes formed also absorb in the 210-= 240-nm region. Currently, this appears to be the best index of LDL oxidizability and is clearly the most popular.
SPECTROPHOTOMETRIC ASSAY FOR LIPID PEROXIDES
This rapid and simple method is based on the oxidation of iodide to iodine by lipid peroxides formed during oxidation of LDL [45] . However, the disadvantage is that the lower detection limit is similar
to the reagent blank and the method measures other peroxides as well.
Another iodometric assay deals with the problem of specificity by hydrolyzing esterified lipids and extracting them with ethyl acetate before determination of their hydroperoxide content [46] . The ferrous ion oxidation assay [47] , in which ferrous ions are oxidized in the presence of xylenol orange, also seems to be relatively specific for lipid peroxides. The most specific and sensitive assay for determination of lipid peroxides in biological fluids is HPLC with isoluminol chemiluminescence detection [48] . However, this assay is time consuming and is not readily adaptable to the clinical laboratory setting.
THIOBARBITURIC ACID-REACTIVE SUBSTANCES (TBARS)

ASSAY
The most commonly used assay in LDL oxidation studies, both in the presence and absence of cells, is the TBARS test [49] . In this test, the chromogen is formed by the reaction of one molecule of MDA with two molecules of TBA. The method involves heating the sample with TBA under acidic conditions and reading the absorbance of the MDA-TBA adduct formed at 532 nm. This test is not specific for MDA, since sugars and amino acids may also form TBA adducts; furthermore, a significant amount of peroxides are formed during the heating step of the assay. Various modifications of the TBA test have been proposed, involving differences in sample treatment, acid concentration, heating time, and presence or absence of antioxidants.
The spectrophotometric test of TBARS [50] includes precipitation of protein with trichioroacetic acid. The assay is conducted in the presence of BHT-EDTA to minimize peroxide formation due to heating. To increase sensitivity, the MDA-TBA adduct can be extracted into an organic solvent (butanol) and measured fluorometrically [51] . Although this test is widely used to assess lipid and atherosclerosis peroxidation, it lacks specificity and should not be the only measure used.
RELATIVE ELECTROPHORETIC MOBILITY
LDL has a negatively charged surface and migrates to the anode in agarose gel electrophoresis under nondenaturing conditions. Oxidation renders LDL more negatively charged, possibly because of derivatization of lysine residues of apo B-100 by some reactive aldehydes formed during oxidation, and accordingly its electrophoretic mobility increases (Fig. 2) . Another possibility for the increase of negative charge on LDL during oxidation is that reactive oxygen species generated convert histidine and proline residues to negatively charged aspartate or glutamate. A measurable index of this is the relative electrophoretic mobility, which is the ratio of migration distance of oxidized to native LDL. This is a very reliable way to quantify LDL oxidation in vitro but it clearly lacks the sensitivity of an in vivo test. Other aldehydic modifications will also alter the electrophoretic mobility of LDL.
APO B-ba FLUORESCENCE
The oxidative modification of LDL also generates fluorophores, which fluoresce strongly at 430 nm with excitation at 360 nm, owing to derivatization of apo B-100 lysine residues by reactive aldehydes [52] . A typical time course of apo B fluorescence is shown in Fig. 2 . This assay has the same problems as discussed for measuring electrophoretic mobility. Although it is a very reliable index of protein modification of LDL during oxidation, the assay is not sensitive enough to measure basal LDL oxidation.
FAYY ACID CONTENT
Since oxidative modification of LDL is essentially a free radicalmediated process involving oxidation of PI.JFAsin LDL, measurement of the fatty acid content could be an indication of the oxidative susceptibility of the LDL particle. This is a good measure of LDL oxidation but is not easily adaptable to the routine laboratory.
OXYSTEROLS
Oxidative modification
of LDL can also be assessed by measuring oxidation products of cholesterol, oxysterols [56] . Although several are produced, 7-ketocholesterol has been identified as the main oxysterol produced during copper-catalyzed and cellmediated oxidation of LDL and can be measured by GC or GC-mass spectrometry (MS) methods. Measurement of oxysterols in human plama can become a test of LDL oxidation.
However, not much data have been reported in this regard.
F2 -ISOPROSTANES
It was recently discovered that a series of structurally unique prostaglandin F2 (PGF2)-like compounds (F2-isoprostanes) are produced in vivo in humans by a noncyclooxygenase mechanism involving free radical-catalyzed peroxidation of arachidonic acid. Of these, 8-epi-PGF2-a, the major component, is a potent vasoconstrictor [57] . The release of PGF2 is increased in LDL oxidized by macrophages, endothelial cells, or copper and can be measured by a solid-phase extraction procedure, followed by GC-MS [57] .The formation of F2-isoprostanes is induced in plasma and LDL exposed to oxidative stress in vitro [58] . Also, as was recently shown, F2-isoprostanes and their metabolites are increased in plasma and urine of smokers [59] . However, although this is a measure of LDL oxidation, measurement in urine reflects whole-body oxidation rather than LDL oxidation.
Since this novel method offers a lot of promise, research should be directed at developing a plasma assay that can be adapted to the clinical laboratory.
Specific fluorescence patterns can be produced when certain amino acids react with lipid peroxides.
Previously, dityrosine fluorescence was shown to be associated with oxidation of linoleic acid [60] . Phagocytes generate myeloperoxidase to kill invading bacteria; this may convert tyrosine to a radical catalyst that cross-links proteins.
The stable oxidized product of the tyrosyl radical is dityrosine; its stability and intense fluorescence may allow it to also act as a marker for oxidatively damaged proteins in lesions. This method could prove useful in evaluating the role of specific protein modifications that occur during lipoprotein oxidation.
Antioxidant Status
ANTIOXIDANTS AND LDL OXIDATION
The antioxidant content of LDL is critical for its protection. In theory, if sufficient lipophilic antioxidants were present, LDL would be protected from even profound oxidant challenge. The balance between the prooxidant challenge and the presence of antioxidants determines the extent of arterial wall modification of LDL. Antioxidants such as probucol, N,N'-diphenyl phenylenediamine, and BHT have been shown to decrease the degree of oxidation and the extent of atheromatous lesions in animal models of atherosclerosis [61] , but have side effects. Thus, dietary antioxidants such as a-tocopherol, a-carotene, and ascorbic acid become attractive alternatives. We have reviewed extensively in previous reports the role of antioxidants in relation to atherosclerosis [5] .
cr-Tocopherol. a-Tocopherol (vitamin E) is the principal lipidsoluble antioxidant in plasma and in the LDL particle [62] . It is a chain-breaking antioxidant and traps peroxyl free radicals. Several studies have associated low a-tocopherol concentrations with the development of atherosclerosis. A cross-sectional study of 16 European populations has shown a significant correlation between a-tocopherol concentrations and mortality from coronary artery disease [63] . A previous study has shown an inverse correlation between plasma vitamin E concentrations and the risk of angina pectoris [64] . Vitamin E supplementation has been shown to reduce the risk of coronary artery disease in men and women [65, 66] , but not in middle-aged smokers from Finland who were receiving 50 mg/day of a-tocopherol for 5 years. The failure of the Finnish study may be attributed to the long period during which the study population was at risk, the relatively late time point when supplementation was initiated, and probably too low a dose of vitamin E administered to inhibit LDL oxidation. Some animal studies [67, 68] have also shown that dietary a-tocopherol can retard the progression of atherosclerosis.
a-Tocopherol
has been shown to inhibit LDL oxidation in vitro, and supplementation of human volunteers with a-tocopherol has been shown to decrease the susceptibility of their LDL to oxidation [5] . A recent dose-response study shows that at least 400 lU/day is required to significantly decrease the susceptibility of LDL to oxidation [69] . a-Tocopherol may also have additional benefits for cardiovascular disease. a-Tocopherol, alone or in combination with ascorbate and 13-carotene, has been shown to reduce platelet adhesion [70] . Physiological concentrations of a-tocopherol also inhibit smooth muscle proliferation, protein kinase C activity [71] , and agonist-induced monocyte adhesion to cultured human endothelial cells [72J. Low-dose supplementation with a-tocopherol has been shown to preserve endothelium-dependent vasodilation in hypercholesterolemic rabbits [73] . [87] . Retinol is measured at 325 nm, a-tocopherol at 292 nm, and the carotenoids at 450 nm.
Another index of the antioxidant status of plasma is the total radical-trapping antioxidant parameter [88] . This is a total estimate of antioxidants present in plasma, such as ascorbate, urate, sulfhydryls, and a-tocopherol.
The activity of antioxidant enzymes such as superoxide dismutase, catalase, and glutathione peroxidase is also determined.
However, this assay does not give information on the individual antioxidants.
Other Measures of Oxidation
Another potential way to evaluate lipoprotein oxidation is by measurement of autoantibodies against epitopes on oxidized LDL [89] by ELISA. A recent study has shown that the titer of these antibodies is an independent predictor of the progression J ialal and Devaraj: LDL oxidation, antioxidants, and atherosclerosis of carotid atherosclerosis in patients with accelerated atherosclerosis [90] .
Nuclear magnetic resonance analysis of oxidized lipoproteins [91] could provide interesting details concerning the structural aspects of these modified lipoproteins.
Breakdown products of lipid peroxides are exhaled in breath as volatile hydrocarbons.
The volatile oxidation products of n-6 and n-3 fatty acids, pentane and ethane, appear in breath and can be measured by GC [92] . This method is sensitive and noninvasive; however, it is tedious and one must purify the inspired air because of the high background created by exogenous sources such as motor vehicles and cigarette smoke. Also, it is a measure of whole-body oxidation and not LDL oxidation specifically.
In conclusion, it has become increasingly evident that oxidation of LDL is a key step in atherogenesis.
Although 
